홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

m-Chloroperbenzoic acid → 3-(Pyridin-3-yloxy)-4,5-dihydroisoxazole

HRID 1746125
인쇄

반응식

HRID 1746125 반응식
N1[CH:6]=[C:5]([O:7][C:8]2[CH2:12][CH2:11][O:10][N:9]=2)[CH:4]=[N:3][CH:2]=1.Cl[C:14]1C=CC=C(C(OO)=O)C=1>C(Cl)Cl>[N:3]1[CH:2]=[CH:14][CH:6]=[C:5]([O:7][C:8]2[CH2:12][CH2:11][O:10][N:9]=2)[CH:4]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

4

반응물 2

HCID 70297m-Chloroperbenzoic acidHCID 866505643-(Pyrimidin-5-yloxy)-4,5-dihydroisoxazole

생성물 1

HCID 668185323-(Pyridin-3-yloxy)-4,5-dihydroisoxazole

시약·촉매·용매 1

HCID 6344Dichloromethane용매

실험 절차

Racemic 3-(pyrimidin-5-yloxy)-4,5-dihydroisoxazole I-132 was dissolved in methylene chloride (0.5 M with respect to isoxazole) after which point m-chloroperbenzoic acid (2.0 equiv) was added in 1 portion and the reaction was allowed to stir at room temperature for 1 h. After the reaction was determined to be complete by LC/MS, the solvent was evaporated. The crude mixture was then redissolved in tert-butylmethyl ether (0.5 M) after which hexane was slowly added until a solid precipitated. The solid was then collected via vacuum filtration and washed with 1:1 hexanes/tert-butylmethyl ether to provide the desired 3-(pyridin-3-yloxy)-4,5-dihydroisoxazole I-133a and I-133b as a white solid. These compounds can be separated using chiral HPLC methods known in the art. For example, see chiral HPLC Method disclosed herein. [M+H]+=404.1 m/z. Activity: A

후처리

  1. additionwas added in 1 portion
  2. customthe solvent was evaporated
  3. dissolutionThe crude mixture was then redissolved in tert-butylmethyl ether (0.5 M) after which hexane
  4. additionwas slowly added until a solid
  5. customprecipitated
  6. filtrationThe solid was then collected via vacuum filtration
  7. washwashed with 1:1 hexanes/tert-butylmethyl ether

출처 및 근거

ORD 기록
ord-0412a288a6ae4290a1ffd82abf71803b
출처 데이터셋
uspto-grants-2015_10
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US09149465B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트